Cronos (CRON) Cash from Investing Activities (2019 - 2026)

Cronos' (CRON) quarterly Cash from Investing Activities came in at $38.0 million in Q1 2026, up 168.7% year-on-year from $14.2 million in Q1 2025, and up 1266.97% quarter-over-quarter from $2.8 million in Q4 2025.

Cronos (CRON) Cash from Investing Activities (2019 - 2026) Analysis & Trends

Cronos' Cash from Investing Activities history runs 8 years deep, the most recent figure standing at $38.0 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 168.7% year-over-year to $38.0 million in Q1 2026; TTM through Mar 2026 was $16.8 million, a 124.12% increase from a year earlier, with the FY2025 full-year figure at -$76.6 million, down 143.71% from the prior year.
  • Cash from Investing Activities rose to $38.0 million in Q1 2026 per CRON's latest filing, from $2.8 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $189.6 million in Q1 2024 and bottomed at -$303.8 million in Q1 2023.
  • The 5-year median for Cash from Investing Activities is -$818000.0 (2024), against an average of $4.4 million.
  • Biggest YoY gain for Cash from Investing Activities was 231.33% in 2023; the steepest drop was 303912.0% in 2023.
  • Year by year, Cash from Investing Activities stood at $158.5 million in 2022, then slumped by 48.32% to $81.9 million in 2023, then tumbled by 106.14% to -$5.0 million in 2024, then soared by 155.29% to $2.8 million in 2025, then surged by 1266.97% to $38.0 million in 2026.
  • Per Business Quant, the three latest CRON Cash from Investing Activities figures stand at $38.0 million (Q1 2026), $2.8 million (Q4 2025), and -$23.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 88.88 Bn 87.01 Bn - -
2 Teva Pharmaceutical Industries 35.92 Bn 32.18 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.31 Bn 30.37 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 23.07 Bn 20.91 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 20.53 Bn 20.53 Bn - -
7 Viatris 20.27 Bn 18.47 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.92 Bn 16.61 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.61 Bn 12.18 Bn 785.00 Mn -60.00 Mn
10 Cronos 1.06 Bn 240.39 Mn 19.15 Mn 38.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 38.03 Mn
Mar 31, 2026 38.03 Mn
Dec 31, 2025 2.78 Mn
Dec 31, 2025 2.78 Mn
Sep 30, 2025 -23.00 Mn
Sep 30, 2025 -23.00 Mn
Jun 30, 2025 -983,000.00
Jun 30, 2025 -983,000.00
Mar 31, 2025 -55.36 Mn
Mar 31, 2025 -55.36 Mn
Dec 31, 2024 -5.03 Mn
Dec 31, 2024 -5.03 Mn
Sep 30, 2024 -818,000.00
Sep 30, 2024 -818,000.00
Jun 30, 2024 -8.56 Mn
Jun 30, 2024 -8.56 Mn
Mar 31, 2024 189.56 Mn
Mar 31, 2024 189.56 Mn
Dec 31, 2023 81.89 Mn
Dec 31, 2023 81.89 Mn